Number of the records: 1
parasympatomimetiká
SYS d010277 LBL 00000cx--j2200000---45-- 005 20240119201121.3 100 $a 19990101asloy0103----ba0 152 $b mesh 250 $a parasympatomimetiká $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 330 1-
$a Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. $8 eng 450 $a parasympatikomimetiká $5 e $8 slo 550 $3 sllk_un_auth*d008916 $Y Miotics $5 B $a miotiká 550 $3 sllk_un_auth*d010275 $Y Parasympathetic Nervous System $5 B $a systém nervový parasympatikový 550 $3 sllk_un_auth*d002800 $Y Cholinesterase Inhibitors $5 F $a inhibítory cholínesteráz 550 $3 sllk_un_auth*d018721 $Y Muscarinic Agonists $5 F $a agonisty muskarínové 686 $a D27.505.696.663.050.675 750 $a Parasympathomimetics $8 eng 801 -0
$a US $b DNLM $c 19990101 801 -2
$a SK $b BA006 $c 19991005 801 -2
$a SK $b BA006 $c 20180209 820 $a note entry term PARASYMPATHOMIMETIC EFFECT: use only for the parasympathomimetic effect of a chemical substance $8 eng 980 $x M
Number of the records: 1